Osteonecrosis in HIV-infected patients;Osteonecrosis en pacientes infectados por HIV

Medicina

Volumn 64, Issue 4, 2004, Pages 325-331

  Bottaro, Edgardo G ^a,d   Figueroa, Raúl H ^a   Scapellato, Pablo G ^a   Vidal, Gabriela I ^a   Rodriguez Brieschke, Maria T ^a   Da Representaçao, Silvia ^a   Seoane, Maria B ^a   Laurido, Marcelo F ^a   Caiafa, Diego ^a   Lopardo, Gustavo ^b   Herrera, Fabian ^c   Cassetti, Isabel ^a,b  

^a Hospital Santojanni Buenos Aires   (Argentina)

^b Centro de Estudios Infectologicos   (Argentina)

^c CEMIC   (Argentina)

^d NONE   (Argentina)

Author keywords

AIDS; HAART; HIV; Osteonecrosis; Protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; CARDIOLIPIN ANTIBODY; PROTEINASE INHIBITOR; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOLISM; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; AVASCULAR NECROSIS; BONE NECROSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; HYPERLIPIDEMIA; HYPOTHESIS; IMMUNITY; INCIDENCE; MALE; PATHOGENESIS; RISK FACTOR; VASCULITIS; WEIGHT BEARING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ARTHRALGIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; PROTEASE INHIBITORS; RISK FACTORS;

EID: 20144366961     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigation. N Engl J Med 1998; 338: 853-60.
2. Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipemia in HIV-infected individuals treated with protease inhibitors. Circulation 1999; 100: 700-5.
3. Dubé MP. Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin Infect Dis 2000; 31: 1467-75.
4. Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000; 30 (suppl 2): S135-42.
5. Tebas P, Powderly WG, Claxton S, et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000; 14: F63-7.
6. Gutiérrez F, Padilla S, Ortega E, et al. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. AIDS 2002; 16: 481-3.
7. Monier P, McKown K, Bronze MS. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis 2000; 31: 1488-92.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
9. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of HDL cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-9.
10. Steinberg ME. Avascular necrosis: diagnosis, staging, and management. J Musculoeskel Med 1997; 14: 13-25.
11. Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 2002; 7: 601-5.
12. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326: 1473-9.
13. Scribner AN, Troia-Cancio PV, Cox BA, et al. Osteonecrosis in HIV: A case-control study. J Acq Imm Defic Synd 2000; 25:19-25.
14. Plate AM, Boyle BA. Review of avascular necrosis and HIV. AIDS Reader 2000; 10: 570-3.
15. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS. Decreased fibrinolytic potential in patients with idiopatic avascular necrosis and transient osteoporosis of the hip. Am J Hematol 1993; 44: 1473-9.
16. Cushner MA, Friedman RJ. Osteonecrosis of the humeral head. J Am Acad Orhop Surg 1997; 5: 339-46.
17. Goorney BP, Lacey H, Thurairajasingam S, Brown JD. Avascular necrosis of the hip in a man with HIV infection. Genitourin Med 1990; 66: 451-2.
18. Rademaker J, Dobro JS, Solomon G. Osteonecrosis and human immunodeficiency virus infection. J Rheumatol 1997; 24: 601-4.
19. Chevalier X, Larget-Piet B, Hernigou P, Gherardi R. Avascular necrosis of the femoral head in HIV-infected patients (letter). J Bone Joint Surg Br 1993; 75:160.
20. Meyer D, Behrens G, Schmidt RE, Stoll M. Osteonecrosis of the femoral head in patients receiving HIV protease inhibitors (letter). AIDS 1999; 13: 1147-8.
21. Calza L, Manfredi R, Mastroianni A, Chiodo F. Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review. AIDS Patient Care and STDs 2001; 15: 385-9.
22. Keruly JC, Chaisson RE, Moore RD. Increasing incidence of avascular necrosis of the hip in HIV-infected patientes. J Acq Immune Defic Syndr 2001; 28: 101-2.
23. Miller KD, Masur H, Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; 137: 17-24.
24. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS 2003; 17: 1-9.
25. Ries MD, Barcohana B, Davidson A, Jergesen HE, Paiement GD. Association between human immunodeficiency virus and osteonecrosis of the femoral head. J Arthrop 2002; 17: 135-9.
26. Bonfanti P, Grabbuti A, Carradori S, et al. Osteonecrosis in protease inhibitor-treated patients. Orthopedics 2001; 24: 271-2.
27. Franzen C, Salzberger B, Fatkenheuer G. Avascular necrosis of both femoral heads in an HIV-infected patient receiving protease inhibitors. Eur J Med Res 2001; 6: 83-4.
28. Cruess RL. Steroid-induced avascular necrosis of the head of the humerus: natural history and treatment. J Bone Joint Surg 1976; 58B: 313-7.
29. Clevenbergh P, Corcostegui M, Gerard D, et al. latrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. J Infect 2002; 44: 194-5.
30. Glesby MJ, Hoover DH, Vaamonde CM. Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study. J Infect Dis 2001; 519-23.
31. Skiest DJ. Osteonecrosis in human immunodeficiency virus infected-patients may not be related to immune reconstitution. Clin Infect Dis 2001; 33: 268-70.
32. Sorice M, Griggi T, Arcieri P, et al. Protein S and HIV infection. The role of anticardiolipin and anti-protein S antibodies. Thromb Res 1994; 73: 165-75.
33. Korompilias AV, Gilkeson GS, Ortel TL, Seaber AV, Urbaniak JR. Anticardiolipin antibodies and osteonecrosis of the femoral head. Clin Orthop 1997; 345: 174-80.
34. de Larrañaga GF, Petroni A, Deluchi G, Alonso BA, Benetucci JA. Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. Blood Coagul Fibrinolysis 2003; 14: 15-8.
35. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDs 2001; 15: 311-20.
36. Epstein NN, Tuffanelli DL, Epstein JH. Avascular bone necrosis. A complication of long-term corticosteroid therapy. Arch Dermatol 1965; 92: 178-80.
37. Koller E, Mann M, Malozowski S, Bacsanyi J, Gibert C. Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate. AIDS Patient Care STDs 2000; 14: 405-10.
38. Laroche M, Ludot I, Thiechart M, Viguier G, Dromer C, Mazieres B. Histological appearance of the intra-osseous vessels of the femoral head in aseptic osteonecrosis of the hip, with or without anti phospholipid antibodies. Clin Rheumatol 1997; 16: 367-71.
39. Kaye BR. Rheumatologic manifestations of infection with human immunodeficiency virus (HIV). Ann Intern Med 1989; 111: 158-67.
40. Calza L, Manfredi R, Chiodo F. Arterial Occlusive disease and osteonecrosis in HIV infection: a common etiologic and pathogenetic mechanism? Infect Dis in Clin Practice 2002; 11: 23-4.
41. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000; 31: 374-9.
42. Hicks JL, Ribbans WJ, Buzzard B, et al. Infected joint replacements in HIV-positive patients with haemophilia. J Bone Joint Surg Br 2001; 83: 1050-4.
43. Lehman CR, Ries MD, Paiement GD, Davidson AB. Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty 2001; 16: 330-5.